I have always been fascinated with the science of genes. What makes one child’s hair straight and another’s curly — when both parents have straight hair? And then when you start thinking about all of the things scientists are learning to do with gene therapy and stem cells, helping to treat and hopefully even cure diseases at a cellular level — fascinating.
When my oldest was born preserving stem cells by cord blood banking was in its infancy and really wasn’t a practical option. By the time my second was born, I planned to donate her cord blood. I don’t like to waste anything, so it made sense to me to donate it to someone who might be able to use (or study it). But sadly, there was a mix up and it was thrown out instead of being donated. I was crushed, all of those stem cells wasted. (I was also hormonal, but to this day I wish they had the potential to help another.)
Cord Blood Banking Options
Expecting parents have two options when it comes to cord blood banking — public or private. With public cord blood banking, the blood is preserved at no-cost to the parents and made available as an anonymous donation either to a person to help treat a disease like leukemia or to scientists to further research.
Private cord blood banking preserves the stem cells for later personal use either by the child or a sibling. Stem cells can currently be used to treat more than 80 blood diseases and with ongoing research into stem cells that list is sure to grow.
StemCyte offers parents the peace of mind of safe cord blood banking with one of the highest rates of transplanted stem cells in the buisness. That means not only is the company collecting cord blood, it is also helping families use the stem cells in the cord blood later in life.
Using a proprietary stem cell optimization process that consistently delivers cell recovery of 99% or higher, StemCyte offers one of the highest numbers of viable stem cells – functional, usable cells preserved years or even decades after their banking – in the industry. StemCyte’s U.S. facility has also maintained accreditation by FACT (Foundation for the Accreditation of Cellular Therapy) since 2006. StemCyte was the first cord blood bank in the world to receive accreditation in all three cord blood banking activities: unrelated, family-related, and autologous cord blood. FACT is known for international standardization of clinical and laboratory practices for all cellular therapies.
Preserving the stem cells in cord blood is like an insurance policy that you hope to never cash in, but since we don’t know how many things will be possible in the future with stem cells it could someday save a life.
For more information about cord blood banking visit StemCyte.